Patents/Assignees

Omeros Corporation

16 patents in portfolio

US12486278utility2025
MASP-2 Inhibitors and Methods of Use
0 cites
US12351648utility2025
Methods of Inhibiting MASP-2 for the Treatment And/or Prevention of Coronavirus-induced Acute Respiratory Distress Syndrome
0 cites
US12195427utility2025
MASP-2 Inhibitors and Methods of Use
0 cites
US12129290utility2024
Monoclonal Antibodies, Compositions and Methods for Detecting Complement Factor D
0 cites
US12110288utility2024
MASP-2 Inhibitors and Methods of Use
0 cites
US12091468utility2024
Therapeutic Antibodies That Bind to the Serine Protease Domain of MASP-2 and Uses Thereof
0 cites
US12030853utility2024
MASP-2 Inhibitors and Methods of Use
0 cites
US12005117utility2024
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
0 cites
US11945848utility2024
Chimeric Inhibitor Molecules of Complement Activation
0 cites
US11883493utility2024
Antibodies Specifically Binding to MASP-3 for the Treatment of Various Diseases and Disorders
0 cites
US11807641utility2023
MASP-2 Inhibitors and Methods of Use
0 cites
US11661418utility2023
MASP-2 Inhibitors and Methods of Use
0 cites
US11628217utility2023
Highly Concentrated Low Viscosity MASP-2 Inhibitory Antibody Formulations, Kits, and Methods
0 cites
US11613589utility2023
Compositions for Inhibiting MASP-2 Dependent Complement Activation
0 cites
US11584714utility2023
MASP-2 Inhibitors and Methods of Use
0 cites
US8343970utility2013
PDE10 Inhibitors and Related Compositions and Methods
0 cites